pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of insulin, when Leonard Thomas, a 14-year-old boy, was treated with the hormone.

Drug Pricing 130

Drug Pricing Diabetes Biosimilars 130

Drug Channels

APRIL 12, 2022

The econowonks at the Centers for Medicare & Medicaid Services (CMS) recently released the latest projections for U.S. spending on healthcare. (See links below.) These data provide our first official look at post-pandemic U.S. healthcare spending. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending.

92

92

Pharma Times

APRIL 12, 2022

Novacyt’s second direct-to-PCR test is the third product to be added to the Coronavirus Test Device Approvals (CTDA) register of approved products

93

93

Outsourcing Pharma

APRIL 14, 2022

The US agencyâs latest draft document lays out guidelines to help increase involvement of underrepresented ethnic and racial populations in clinical research.

Documentation 98

Documentation 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

APRIL 12, 2022

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The Department of Health, NHS England and NICE have completed an evaluation of two new antibiotics – Pfizer’s Zavicefta (ceftazidime/avibactam) and Shionogi’s Fetcroja (cefiderocol) – that will be paid for using the new subscription-like model likened to a Netflix account.

118

118

NY Times

APRIL 13, 2022

The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their pitch.

96

96

Outsourcing Pharma

APRIL 12, 2022

A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research field.

96

96

pharmaphorum

APRIL 11, 2022

In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation Fund), pharmaphorum discusses the recent announcement of the closing of a $25 million Series A financing round to scale up the innovative VivoSense® software, which uses wearable sensor data in clinical trials, and for the development of novel digital biomarkers.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Drug Development Packaging 111

NY Times

APRIL 11, 2022

The chemical derived from psychedelic mushrooms helped alleviate symptoms of depression and generated detectable neural responses that lasted weeks.

98

98

Pharma Times

APRIL 11, 2022

The biologics development and manufacturing facility is currently under construction near Oxford, UK

110

110

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Drug Patent Watch

APRIL 13, 2022

This chart shows the drugs with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.

87

87

pharmaphorum

APRIL 11, 2022

Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full value of medicines. Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. As an oncology trained medical doctor who practiced in the UK NHS for 10 years, I have seen the benefits first-hand, as patients live longer lives, free from symp

Pharmaceutical Companies 114

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 114

NY Times

APRIL 15, 2022

The more rapidly we are able to produce safe, effective drugs for quick-spreading pathogens like the coronavirus, the more lives we can save.

97

97

Pharma Times

APRIL 12, 2022

Engetix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD

101

101

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Eye on FDA

APRIL 13, 2022

We are four months into the year, and this week OPDP has issued its fourth regulatory action letter of 2022. Two of the previous were Warning Letters, considered the more serious of the two categories, and two, including the latest, were Untitled Letters. As noted in past updates, FDA’s OPDP enforcement letters have dropped off considerably over the years.

Communication 82

Communication Packaging 82

pharmaphorum

APRIL 13, 2022

GlaxoSmithKline has agreed a deal to buy Sierra Oncology and its lead drug momelotinib for anaemia associated with the blood cancer myelofibrosis, sending the US biotech’s shares skywards. GSK is paying $55 per share in cash for Sierra – a 39% premium to its closing share price yesterday – which values the company at around $1.9 billion. Shares in Sierra were up 38% in pre-market trading this morning.

Vaccines 104

Vaccines 104

NY Times

APRIL 11, 2022

A late-stage trial was halted after strong early results, according to the company, but the data have not yet been published or peer-reviewed.

94

94

Pharma Times

APRIL 11, 2022

Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients

107

107

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

APRIL 12, 2022

Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.

Drug Development 89

Drug Development 89

pharmaphorum

APRIL 12, 2022

Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to understand a patient’s prescription journey and who influences prescription-based decisions. The healthcare landscape has shifted dramatically due to the pandemic.

Communication 98

Communication 98

Drug Patent Watch

APRIL 14, 2022

Annual Drug Patent Expirations for ARISTADA Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are fifteen patents…. The post New patent for Alkermes Inc drug ARISTADA appeared first on DrugPatentWatch - Make Better Decisions.

79

79

Pharma Times

APRIL 14, 2022

Approval demonstrates significant step forward in the treatment of adult advanced NSCLC patients with METex14

100

100

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Channels

APRIL 11, 2022

Informa Connect's Life Sciences Commercial Contracts & Chargebacks 2022 Hybrid. May 24-25, 2022 | Philadelphia, PA www.informaconnect.com/contracts-chargebacks. Save 10% by using code 22DC10. The Life Sciences Commercial Contracts and Chargebacks conference returns as a hybrid event May 24-25 with the options of attending in-person in Philadelphia or virtually.

73

73

pharmaphorum

APRIL 11, 2022

GripAble has raised $11 million in first-round financing that will be used to advance its digital health approach to rehabilitation for people with neurological and musculoskeletal conditions on the international stage. The London, UK-based company has developed a platform that combines a hand-held sensor, gamified mobile app software, and telehealth consultations with therapists, which is designed to entertain users while they train at home.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies 104

Drug Patent Watch

APRIL 11, 2022

This chart shows the drugs with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical drugs have the most drug patents in Hong Kong? appeared first on DrugPatentWatch - Make Better Decisions.

68

68

Pharma Times

APRIL 14, 2022

Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer

97

97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Channels

APRIL 15, 2022

Today’s guest post comes from Megan Marchal, Director of Specialty Pharmacy Strategy at CoverMyMeds. Megan discusses the access and affordability challenges faced by specialty therapy patients. She describes how CoverMyMeds’ centralized technology solutions—paired with experts familiar with each therapy—help patients navigate these challenges. And, she shares one patient’s personal journey.

Specialty Pharmacies 73

Specialty Pharmacies 73

pharmaphorum

APRIL 12, 2022

Novartis has joined the select cadre of drugmakers developing KRAS inhibitors for cancer, opening its account with phase 1b data on JDQ443 showing efficacy in KRAS-mutated non-small cell lung cancer (NSCLC). The results – presented at the American Association of Cancer Research (AACR) congress – set Novartis off in pursuit of Amgen, whose Lumakras (sotorasib) is already on the market, and Mirati Therapeutics which has adagrasib under review by the FDA.

98

98

The Honest Apothecary

APRIL 15, 2022

Mark Cuban. The internet has been all astir for months about the entrance of billionaire Mark Cuban into the pharmacy market with his CostPlus pharmacy model – touted to save consumers money. His mission sounds altruistic enough, and I have even heard some describe his purpose as “philanthropic.” I have no bones to pick with a creative entrepreneur who has found a new way to make a buck.

52

52

Pharma Times

APRIL 13, 2022

Companies will support a study which provides vital information on arthritis for patient-supporting HCPs

92

92

Drug Patent Watch

APRIL 15, 2022

This chart shows the pharmaceutical companies with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Peru? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52